ACTIVE_NOT_RECRUITING

Men Moving Forward: A Lifestyle Program for African-American Prostate Cancer Survivors

Conditions

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This study will examine the efficacy of Men Moving Forward (MMF), a four-month community-based lifestyle intervention designed for AA PC survivors. MMF is rooted in the evidence-based Moving Forward lifestyle intervention developed with and for AA breast cancer survivors. This intervention was adapted in collaboration with AA PC survivors. It will offer twice weekly sessions aimed at supporting adherence to the ACS nutrition and physical activity guidelines to promote improved body composition (i.e., decreased adiposity, increased lean mass).

Official Title

Men Moving Forward: A Lifestyle Program for African-American Prostate Cancer Survivors

Quick Facts

Study Start:2019-06-01

Study Completion:2026-05-30

Study Type:Not specified

Phase:Not Applicable

Enrollment:Not specified

Status:ACTIVE_NOT_RECRUITING

Study ID

NCT03971591

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years

Sexes Eligible for Study:MALE

Accepts Healthy Volunteers:No

Standard Ages:ADULT, OLDER_ADULT

Inclusion Criteria	Exclusion Criteria
* Age 18 years and older * Self-identify as Black or African American * Diagnosed with non-metastatic Prostate Cancer (cancer that has NOT spread elsewhere in the body) * Completed all treatments (including Androgen Deprivation Therapy) at least six months prior to enrollment * BMI \> 25 kg/m2 * Able to participate in moderate physical activity as assessed by healthcare provider * Exercise less than the ACS recommended guideline of 150 min/week or 30 min/day. * Fruit and vegetable consumption is less than 5 servings each day. * Lift Weights or engage in strength training less than twice a week. * Can walk continuously for 5 minutes without stopping because of pain or shortness of breath. * Have access to a mobile phone * Approval from Primary Care Provider/Medical Oncologist * Available to attend intervention	* • Does not meet the Inclusion Criteria

Inclusion Criteria

Exclusion Criteria

* Age 18 years and older
* Self-identify as Black or African American
* Diagnosed with non-metastatic Prostate Cancer (cancer that has NOT spread elsewhere in the body)
* Completed all treatments (including Androgen Deprivation Therapy) at least six months prior to enrollment
* BMI \> 25 kg/m2
* Able to participate in moderate physical activity as assessed by healthcare provider
* Exercise less than the ACS recommended guideline of 150 min/week or 30 min/day.
* Fruit and vegetable consumption is less than 5 servings each day.
* Lift Weights or engage in strength training less than twice a week.
* Can walk continuously for 5 minutes without stopping because of pain or shortness of breath.
* Have access to a mobile phone
* Approval from Primary Care Provider/Medical Oncologist
* Available to attend intervention

* • Does not meet the Inclusion Criteria

Contacts and Locations

Study Locations (Sites)

Medical College of Wisconsin

Milwaukee, Wisconsin, 53226

United States

Collaborators and Investigators

Sponsor: Medical College of Wisconsin

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2019-06-01

Study Completion Date2026-05-30

Study Record Updates

Study Start Date2019-06-01

Study Completion Date2026-05-30

Terms related to this study

Additional Relevant MeSH Terms

Prostate Cancer